Vector-Best - Predicting the success of HCV therapy

01.09.2023

CE Mark for the PCR kits More

01.09.2023

August 16-18, Bangkok, Thailand AO Vector-Best participated in the Medlab Asia & Asia health More

25.07.2023

May 29, Belgrade: AO Vector-Best in collaboration with the Ministry of Health of the Republic of Serbia and the Institute of Public Health of Serbia, held a conference «Laboratory technologies for diagnostics: an open dialogue between the laboratory community of Serbia and a leading Russian manufacturer of IVD kits».
To watch conference video follow the link https://youtu.be/DUWI9yLRh24

20.07.2023

Vector-Best company will participate as silver partner in the Medlab Asia & Asia Health 2023 (Hall 6, stand № B39). 16-18 August 2023, Impact Exhibition Centre, Bangkok, Thailand.
For more information about our company and other exhibitors, follow the Medlab Asia & Asia Health youtube channel.

22.06.2023

New reagent kits for the diagnosis acute intestinal infections:
RealBest RNA Norovirus GI/Norovirus GII
RealBest RNA Rotavirus A/Astrovirus
RealBest DNA Salmonella spp./Adenovirus F
RealBest DNA Campylobacter (thermophilic spp.)/Shigella spp.,EIEC

Production » PCR » Single nucleotide polymorphisms (SNPs) and mutations in human genes » Predicting the success of HCV therapy

Cat. No.	Kit name	Format	Number of tests
3811	RealBest-Genetics Interleukin 28B Gene: polymorphism - IL28B: rs12979860 C/T; rs8099917 T/G	Str	48

Cat. No.

Kit name

Format

Number of tests

3811

RealBest-Genetics Interleukin 28B

Gene: polymorphism - IL28B: rs12979860 C/T; rs8099917 T/G

Str